Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_assertion type Assertion NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_head.
- NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_assertion description "[MTHFR C677T and MTRR A66G were found to increase the risk for CAD by 1.61-fold (95% CI: 1.04-2.50) and 1.92-fold (95% CI: 1.29-2.87) whereas TYMS 2R allele was found to reduce the risk for CAD (OR: 0.66, 95% CI: 0.49-0.88) by counteracting MTHFR and MTRR variant alleles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_provenance.
- NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_assertion evidence source_evidence_literature NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_provenance.
- NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_assertion SIO_000772 20962453 NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_provenance.
- NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_assertion wasDerivedFrom befree-20140225 NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_provenance.
- NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_assertion wasGeneratedBy ECO_0000203 NP275137.RAXJ8YldotxCZ2cKL4t1eLoQR1f4Xkszw2iF8N4RTIg2M130_provenance.